Pulmonary Edema News and Research

RSS

RAS inhibitors and COVID-19 severity in hypertensive patients

A new study published in the journal JAMA Cardiology in April 2020 reports that patients with hypertension who are taking medications called ACE inhibitors (ACEI) or ARBs are not at higher risk for death or more severe illness with COVID-19. This conclusion supports current guidelines for the treatment of hypertension during this pandemic.

23 Apr 2020

COVID-19 lung injury is not like high altitude pulmonary edema

A group of researchers with experience in treating high altitude pulmonary edema have written to correct the misconception in medical social media forums and elsewhere that the lung injury seen in COVID-19 is not like typical acute respiratory distress syndrome and is instead like HAPE.

20 Apr 2020

Neutrophil extracellular traps could cause organ damage in malaria

Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of the disease are accompanied by tissue damage and result in potentially fatal organ failure.

21 Oct 2019

Early planned delivery reduces impact of preterm pre-eclampsia

Doctors have long debated over the optimal time to deliver mothers with pre-eclampsia in late pregnancy (after 34 but before 37 completed weeks). This is because too early delivery compromises the baby’s health, while delayed action may endanger the mother’s health.

29 Aug 2019

Vortex flow closely linked to pressure differences in ventricles of the heart

Japanese scientists at Tokyo University of Agriculture and Technology, Teikyo University of Science, and Juntendo University have found -- in animal studies -- a close relationship between vortex flow and pressure differences in the ventricles, or lower chambers, of the heart.

24 Jun 2019

Liquorice tea linked to hypertensive emergency – a case report

An 84-year-old man was admitted with hypertensive (high blood pressure) emergency after consuming a large amount of licorice tea.

28 May 2019

KAIST research team finds cause of sepsis-induced lung injury

A KAIST research team succeeded in visualizing pulmonary microcirculation and circulating cells in vivo with a custom-built 3D intravital lung microscopic imaging system.

7 May 2019

Crackling and wheezing could be the sounds of a progressing lung disease

Doctors know they're the sounds of lung problems, but it turns out they might be more than symptoms--crackling and wheezing could be the sounds of a disease progressing, a University of Michigan researcher has found.

16 Apr 2019

Studies address racial disparities in postpartum period and cardiovascular health

Cardiovascular disease and hypertensive disorders are leading causes of maternal morbidity and mortality. Two studies will be presented on February 14, 2019, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, that address racial disparities in the postpartum period with a special focus on cardiovascular health.

13 Feb 2019

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

FDA approves new treatment for people with hairy cell leukemia

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

30 Aug 2018

Study improves understanding of preeclampsia heart damage in pregnancy

Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form of a blood pressure disorder has added to evidence that the condition - known as preeclampsia - mainly damages the heart's ability to relax between contractions, making the organ overworked and poor at pumping blood.

6 Aug 2018

Researchers success in transplanting bioengineered human lungs into pigs

Researchers have successfully transplanted bioengineered lungs into pigs, without any complications arising.

6 Aug 2018

New target for pneumonia seems to restore tight barriers and fluid clearance in the lungs

Severe pneumonia causes a buildup of fluid in the lungs that makes the basics of breathing and getting oxygen out to the body difficult to impossible.

25 Jul 2018

New guidelines aim to improve quality of high altitude medicine

The aim of these guidelines is to standardize data capture in this area of research and thereby guarantee and indeed improve the quality of clinical research. Scientists from Eurac Research led the evaluation and coordinated the group of experts.

27 Feb 2018

Debate sessions at Acute Cardiovascular Care 2018 to focus on treatment for heart attack patients

The optimal treatment for heart attack patients will be debated at Acute Cardiovascular Care 2018. The annual congress of the Acute Cardiovascular Care Association, a registered branch of the European Society of Cardiology, will be held 3 to 5 March at the MiCo Milano Congressi in Milan, Italy.

5 Feb 2018

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

It has been amply proven that smoking can cause serious diseases such as emphysema and cancer. A new study, however, shows that pharmacological stimulation of a specific type of nicotinic receptor in cells of the immune system could be a strategy to treat inflammatory lung disease.

20 Oct 2017

Sodium channels play important role in keeping tiny lung capillaries from leaking, worsening pneumonia

Sodium channels in the cells that line the tiny capillaries in our lungs play an important role in keeping those capillaries from leaking and potentially worsening conditions like pneumonia, scientists report.

6 Sep 2017